BastionY., BlayJ.Y., DivineM.: Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival - a Groupe d'Etude des Lymphomes de 1’ Adulte study on 453 patients older than 65 years. J Clin Oncol, 15: 2945–2953, 1997.
2.
Coiffier: Blood, 98: 725a, abs, 3025, 2001.
3.
DixonD.O., NeilanB., JonesS.E., LipschitzD.A., MillerT.P., GrozeaP.N., WilsonH.E.: Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. J Clin Oncol, 4: 295–305, 1986.
4.
GomezH., HidalgoM., CasanovaL., ColomerR., PenD.L., OteroJ., RodriguezW., CarracedoC., Cortes-FunesH., VallejosC.: Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis. J Clin Oncol, 16: 2065–2069, 1998.
5.
MeyerR.M., BrowmanG.P., SamoshM.L., BengerA.M., Bryant-LukosiusD., WilsonW.E., FrankG.L., LeberB.F., SternbachM.S., FosterG.A.: Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma. J Clin Oncol, 13: 2386–2393, 1995.
6.
O'ConnellM.J., EarleJ.D., HarringtonD.P., JohnsonG.J., GlickJ.H.: Initial chemotherapy doses for elderly patients with malignant lymphoma. J Clin Oncol, 4: 1418, 1986.
SonneveldP., De RidderM., Van der LelieH., NieuwenhuisK., SchoutenH., MulderA., Van ReijswoudI., HopW., LowenbergB.: Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy. J Clin Oncol, 13: 2530–2539, 1995.
9.
TirelliU., ZagonelV., ErranteD., FratinoL., MonfardiniS.: Treatment of non-Hodgkin's lymphoma in the elderly: an update. Hematol Oncol, 16: 1–13, 1998.
